Phio Pharmaceuticals (PHIO) executive Kontulis gave up 657 shares at $5.20 to cover taxes or an exercise price
Insider transactions reported
Caitlin Kontulis (executive at Phio Pharmaceuticals Corp., PHIO) reported that they gave up 657 shares at $5.20 to cover taxes or an exercise price on Feb 15, 2023. After these transactions the filing shows 7,994 shares held directly.
- Reporting person
- Kontulis Caitlin
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 15, 2023 | Shares withheld for taxes or exercise price (F) | Common stock, $0.0001 par value1, 2 | -657 | $5.20 | $3,416 | 7,994 direct |
Holdings before and after
- Common stock, $0.0001 par value: 8,651 to 7,994 direct
Footnotes from the filing
- 1. The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
- 2. Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12.
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Kontulis report in this PHIO Form 4?
Caitlin Kontulis (executive at Phio Pharmaceuticals Corp., PHIO) reported that they gave up 657 shares at $5.20 to cover taxes or an exercise price on Feb 15, 2023. After these transactions the filing shows 7,994 shares held directly.
How many PHIO shares does Kontulis hold after this filing?
The filing shows 7,994 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for PHIO
Earlier insider filings at PHIO
- Dec 15, 2022SEC Form 4: Bitterman Robert J bought $780 worth of shares (2,000 units at $0.39), increasing direct ownership by 3% to 74,541 units
- Dec 8, 2022SEC Form 4: Bitterman Robert J bought $780 worth of shares (2,000 units at $0.39), increasing direct ownership by 3% to 72,541 units
- Dec 6, 2022SEC Form 4: Bitterman Robert J bought $860 worth of shares (2,000 units at $0.43), increasing direct ownership by 3% to 70,541 units
- Dec 5, 2022SEC Form 4: Ferrara Robert L bought $2,041 worth of shares (5,000 units at $0.41), increasing direct ownership by 20% to 30,000 units
- Nov 29, 2022SEC Form 4: Bitterman Robert J bought $1,136 worth of shares (2,715 units at $0.42), increasing direct ownership by 4% to 68,541 units
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow PHIO and get a push notification the moment its next story breaks.